Inhibition of theophylline clearance by troleandomycin (Q40641935)

22 September 2017

title

Inhibition of theophylline clearance by troleandomycin (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

2 March 2023

M. Weinberger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300083

2 March 2023

D. Hudgel

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300083

2 March 2023

S. Spector

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300083

2 March 2023

C. Chidsey

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300083

2 March 2023

language of work or name

English

0 references

publication date

1 March 1977

1 reference

full work available at URL

22 September 2017

https://api.elsevier.com/content/article/PII:0091674977901543?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

https://api.elsevier.com/content/article/PII:0091674977901543?httpAccept=text/plain

2 March 2023

1 reference

Crossref

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

The Journal of Allergy and Clinical Immunology

2 March 2023

published in

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

page(s)

228-231

1 reference

The use of macrolide antibiotic substances in the treatment of asthma

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

Cholestatic hepatitis caused by esters of erythromycin and oleandomycin

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

Rational Intravenous Doses of Theophylline

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children.

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

Precipitation of acute ergotism by triacetyloleandomycin

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

Inhibition of drug metabolism by chloramphenicol

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

Relationship of urinary metabolites of theophylline to serum theophylline levels

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/0091-6749(77)90154-3

2 March 2023

Identifiers

1 reference

22 September 2017

1 reference